Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

10.08USD
8 Dec 2017
Change (% chg)

$0.45 (+4.67%)
Prev Close
$9.63
Open
$9.70
Day's High
$10.44
Day's Low
$9.40
Volume
18,118
Avg. Vol
30,197
52-wk High
$15.75
52-wk Low
$5.48

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
FY 2015 Dec '15 0.01 -3.205
Sep '15 0.01 -2.654
Jun '15 0.01 -5.191
Mar '15 0.01 -4.760
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 1 5.30 5.30 5.30 --
Year Ending Apr-18 1 12.20 12.20 12.20 --
Year Ending Apr-19 1 14.40 14.40 14.40 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 1 -0.16 -0.16 -0.16 --
Year Ending Apr-18 1 -1.21 -1.21 -1.21 --
Year Ending Apr-19 1 -1.40 -1.40 -1.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.13 35.51
P/E High - Last 5 Yrs. -- 40.67 45.27
P/E Low - Last 5 Yrs. -- 23.64 24.24
Beta -- 0.92 0.91
Price to Sales (TTM) 210.55 3.92 5.83
Price to Book (MRQ) 3.66 4.88 5.68
Price to Tangible Book (MRQ) 3.66 5.74 7.26
Price to Cash Flow (TTM) -- 23.07 24.44
% Owned Institutions 83.11 0.85 1.39

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.28 5.23
Payout Ratio(TTM) -- 47.28 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 6.31 6.82
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 5.18 5.65
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 7.15 7.23
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.89 10.90
Capital Spending - 5 Yr. Growth Rate -- 15.17 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.54
Current Ratio (MRQ) 7.87 3.51 3.56
LT Debt to Equity (MRQ) 0.80 10.90 13.23
Total Debt to Equity (MRQ) 1.55 17.04 19.24
Interest Coverage (TTM) -29.72 49.98 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.80
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 18.39 15.52
Operating Margin (TTM) -4,529.25 14.77 6.76
Operating Margin - 5 Yr. Avg. -- 14.38 11.03
Pre-Tax Margin (TTM) -4,120.21 15.22 7.58
Pre-Tax Margin - 5 Yr. Avg. -- 14.69 11.44
Net Profit Margin (TTM) -4,120.21 11.39 3.81
Net Profit Margin - 5 Yr. Avg. -- 11.02 7.73
Effective Tax Rate (TTM) -- 24.35 24.25
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 952,857,028 858,823,705
Net Income/Employee (TTM) -- 111,290,090 100,224,560
Receivable Turnover (TTM) -- 5.92 6.12
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 0.01 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.89 11.35
Return on Assets - 5 Yr. Avg. -- 12.90 12.32
Return on Investment (TTM) -60.80 15.10 14.47
Return on Investment - 5 Yr. Avg. -- 16.88 16.13
Return on Equity (TTM) -61.05 16.59 16.06
Return on Equity - 5 Yr. Avg. -- 17.87 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 69.63%
# of Holders: 21
Total Shares Held: 6,762,761
3 Mo. Net Change: -1,087,210
# New Positions: 1
# Closed Positions: 4
# Increased Positions: 8
# Reduced Positions: 6
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.